Influence of protein binding and severity of illness on renal elimination of four cephalosporin drugs in intensive-care patients
- 1 April 1987
- journal article
- Published by Springer Nature in International Journal of Clinical Pharmacy
- Vol. 9 (2) , 98-103
- https://doi.org/10.1007/bf01960743
Abstract
A pharmacokinetic study after a single dose of ceftriaxone, cefoxitin, cefuroxime and ceftazidime was performed to investigate the influence of protein binding and severity of disease on the renal elimination. In intensive-care patients drug-protein binding was substantially less compared to that in volunteers and patients with less complicated diseases. This did not result in increased elimination but, due to increased apparent volumes of distribution, prolonged half-life times were observed. Consequently, in patients with complicated disease states a dosage regimen should be based on pharmacokinetic studies performed in a similar patient group.Keywords
This publication has 21 references indexed in Scilit:
- The Clinical Relevance of Protein Binding and Tissue Concentrations in Antimicrobial TherapyClinical Pharmacokinetics, 1986
- Free Drug Concentration Monitoring in Clinical PracticeClinical Pharmacokinetics, 1986
- Ceftriaxone pharmacokinetics in patients with various degrees of renal impairmentAntimicrobial Agents and Chemotherapy, 1984
- Protein Binding and Drug ClearanceClinical Pharmacokinetics, 1984
- Kinetic disposition of intravenous ceftriaxone in normal subjects and patients with renal failure on hemodialysis or peritoneal dialysisAntimicrobial Agents and Chemotherapy, 1984
- Pharmacokinetic characteristics of intravenous ceftriaxone in normal adultsAntimicrobial Agents and Chemotherapy, 1982
- Clinical pharmacology: plasma protein binding of drugs.BMJ, 1981
- CefoxitinDrugs, 1979
- Diseases and Drug Protein BindingClinical Pharmacokinetics, 1978
- Cefuroxime: Human PharmacokineticsAntimicrobial Agents and Chemotherapy, 1976